• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常肾功能和肾功能受损的高血压患者中吲哚洛尔的可利用性。

Pindolol availability in hypertensive patients with normal and impaired renal function.

作者信息

Chau N P, Weiss Y A, Safar M E, Lavene D E, Georges D R, Milliez P L

出版信息

Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):505-10. doi: 10.1002/cpt1977225part1505.

DOI:10.1002/cpt1977225part1505
PMID:913016
Abstract

Intravenous and oral pharmacokinetics of pinlolol were studied in 18 hypertensive patients-9 with normal renal function and 9 with impaired renal function. Analysis of data showed that a linear two-compartment model was suitable to describe the pindolol kinetics. Compared with patients with normal renal function, patients with chronic renal failure exhibited: (1) unchanged transfer rate constants and distribution volumes and (2) decreased total body clearance with decreased renal clearance and unchanged nonrenal clearance. Analysis of oral data by the Loo-Riegelman method showed that the pindolol absorption kinetic was not first order. Compared with patients with normal renal function, patients with chronic renal failure exhibited decreased fraction of dose effectively absorbed and increased initial rate of absorption. The initial rate of absorption was inversely correlated with the creatinine clearance. The study disclosed evidence that absorption was modified in chronic renal failure.

摘要

在18例高血压患者中研究了心得平的静脉和口服药代动力学,其中9例肾功能正常,9例肾功能受损。数据分析表明,线性二室模型适合描述心得平的动力学。与肾功能正常的患者相比,慢性肾衰竭患者表现为:(1)转运速率常数和分布容积不变;(2)全身清除率降低,肾清除率降低而非肾清除率不变。用Loo-Riegelman方法分析口服数据表明,心得平的吸收动力学不是一级的。与肾功能正常的患者相比,慢性肾衰竭患者有效吸收剂量分数降低,初始吸收速率增加。初始吸收速率与肌酐清除率呈负相关。该研究揭示了慢性肾衰竭时吸收发生改变的证据。

相似文献

1
Pindolol availability in hypertensive patients with normal and impaired renal function.正常肾功能和肾功能受损的高血压患者中吲哚洛尔的可利用性。
Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):505-10. doi: 10.1002/cpt1977225part1505.
2
Pharmacokinetics of intravenous and oral pindolol in hypertensive patients with chronic renal failure.慢性肾功能衰竭高血压患者静脉注射与口服吲哚洛尔的药代动力学
Clin Sci Mol Med Suppl. 1978 Dec;4:275s-277s. doi: 10.1042/cs055275s.
3
Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function.高血压患者在肾功能正常和受损情况下吲哚洛尔的药代动力学及肝脏摄取率
J Clin Pharmacol. 1977 Aug-Sep;17(8-9):501-8. doi: 10.1002/j.1552-4604.1977.tb05643.x.
4
Relationship between renal function and elimination kinetics of pindolol in man.人体中肾功能与吲哚洛尔消除动力学之间的关系。
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):115-6. doi: 10.1007/BF00614006.
5
Prazosin kinetics in essential hypertension.原发性高血压中哌唑嗪的动力学
Clin Pharmacol Ther. 1980 Jul;28(1):6-11. doi: 10.1038/clpt.1980.123.
6
Effects of pindolol on renal function II. Effects on intravenous and prolonged oral dosing.吲哚洛尔对肾功能的影响II. 对静脉注射及长期口服给药的影响
Clin Pharmacol Ther. 1982 Oct;32(4):423-7. doi: 10.1038/clpt.1982.183.
7
Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration.肾小球滤过正常和降低的高血压患者在急性和长期服用吲哚洛尔治疗期间的肾功能
Br J Clin Pharmacol. 1982;13(Suppl 2):237S-240S. doi: 10.1111/j.1365-2125.1982.tb01920.x.
8
The pharmacokinetics of unchanged pindolol in patients with impaired renal function.肾功能受损患者中未代谢的吲哚洛尔的药代动力学。
Br J Pharmacol. 1973 Mar;47(3):620P-621P.
9
Metabolism of pindolol in patients with renal failure.肾衰竭患者中吲哚洛尔的代谢
Eur J Clin Pharmacol. 1982;22(5):423-8. doi: 10.1007/BF00542547.
10
Furosemide kinetics in renal failure.肾衰竭时呋塞米的动力学
Clin Pharmacol Ther. 1978 Jun;23(6):644-50. doi: 10.1002/cpt1978236644.

引用本文的文献

1
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.体外治疗β-肾上腺素能拮抗剂中毒:EXTRIP 工作组的系统评价和建议。
Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.
2
Bioavailability prediction based on molecular structure for a diverse series of drugs.基于分子结构对多种药物进行生物利用度预测。
Pharm Res. 2004 Jan;21(1):68-82. doi: 10.1023/b:pham.0000012154.09631.26.
3
Pharmacokinetics of quinine in patients with chronic renal failure.
慢性肾功能衰竭患者中奎宁的药代动力学。
Eur J Clin Pharmacol. 1996;49(6):497-501. doi: 10.1007/BF00195937.
4
Influence of renal function on the pharmacokinetics of diacerein after a single oral dose.单次口服给药后肾功能对双醋瑞因药代动力学的影响。
Eur J Drug Metab Pharmacokinet. 1994 Jan-Mar;19(1):13-9. doi: 10.1007/BF03188817.
5
Elimination kinetics of labetalol in severe renal failure.重度肾衰竭患者中拉贝洛尔的消除动力学
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):81S-86S. doi: 10.1111/j.1365-2125.1982.tb01893.x.
6
A standard approach to compiling clinical pharmacokinetic data.一种汇编临床药代动力学数据的标准方法。
J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.
7
Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.人体内β-肾上腺素受体阻滞剂的结构与药代动力学之间的定量关系。
J Pharmacokinet Biopharm. 1984 Jun;12(3):263-87. doi: 10.1007/BF01061721.
8
Does alpha 1-acid glycoprotein reduce the unbound metabolic clearance of disopyramide in patients with renal impairment?α1-酸性糖蛋白是否会降低肾功能不全患者体内丙吡胺的游离代谢清除率?
Eur J Clin Pharmacol. 1988;35(3):313-7. doi: 10.1007/BF00558271.
9
Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.β-肾上腺素能受体拮抗剂的临床药代动力学。最新进展。
Clin Pharmacokinet. 1987 May;12(5):305-20. doi: 10.2165/00003088-198712050-00001.
10
Clinical pharmacokinetics in organ transplant patients.器官移植患者的临床药代动力学
Clin Pharmacokinet. 1989 Mar;16(3):134-61. doi: 10.2165/00003088-198916030-00002.